1. Cross labeling oncology drugs in combination regimens: guidance for industry Publication: Silver Spring, MD : Center for Drug Evaluation and Research, November 2022 Subject(s): Antineoplastic Combined Chemotherapy ProtocolsDrug Labeling -- legislation & jurisprudenceGovernment RegulationUnited StatesUnited States. Food and Drug Administration
